JCR Pharmaceuticals Co., Ltd.
4552.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥59,932 | ¥104,824 | ¥175,647 | ¥279,237 |
| - Cash | ¥13,196 | ¥18,756 | ¥13,278 | ¥30,733 |
| + Debt | ¥38,105 | ¥23,300 | ¥22,800 | ¥18,100 |
| Enterprise Value | ¥84,841 | ¥109,368 | ¥185,169 | ¥266,604 |
| Revenue | ¥33,072 | ¥42,871 | ¥34,343 | ¥51,082 |
| % Growth | -22.9% | 24.8% | -32.8% | – |
| Gross Profit | ¥21,548 | ¥31,251 | ¥25,457 | ¥40,621 |
| % Margin | 65.2% | 72.9% | 74.1% | 79.5% |
| EBITDA | -¥2,885 | ¥10,528 | ¥7,453 | ¥21,394 |
| % Margin | -8.7% | 24.6% | 21.7% | 41.9% |
| Net Income | -¥4,758 | ¥5,507 | ¥3,772 | ¥14,507 |
| % Margin | -14.4% | 12.8% | 11% | 28.4% |
| EPS Diluted | -38.43 | 43.92 | 30.22 | 116.79 |
| % Growth | -187.5% | 45.3% | -74.1% | – |
| Operating Cash Flow | -¥5,486 | ¥9,312 | -¥5,500 | ¥9,289 |
| Capital Expenditures | -¥9,888 | -¥2,095 | -¥8,560 | -¥11,333 |
| Free Cash Flow | -¥15,374 | ¥7,217 | -¥14,060 | -¥2,044 |